New drug tezepelumab tested for stuffy nose and polyps

NCT ID NCT07399665

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study looks at how well tezepelumab works for adults with chronic sinusitis and nasal polyps (with or without asthma). About 110 people will be followed for up to a year to see if their nasal polyps shrink and congestion improves. The goal is to understand real-world benefits of this medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)

Contacts and locations

Locations

Research Site
RECRUITING

Kazan', Russia
Research Site
RECRUITING

Kemerovo, Russia
Research Site
RECRUITING

Krasnoyarsk, Russia
Research Site
RECRUITING

Lermontov, Russia
Research Site
RECRUITING

Moscow, Russia
Research Site
RECRUITING

Rostov-on-Don, Russia
Research Site
RECRUITING

Ryazan, Russia
Research Site
RECRUITING

Saint-Petesburg, Russia
Research Site
RECRUITING

Ulyanovsk, Russia
Research Site
RECRUITING

Yekaterinburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.